NITI Aayog Roadmap for India’s Bioeconomy Context:NITI Aayog released the report "Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035", proposing a ₹50,000-crore BioEconomy Growth Fund, a dedicated PLI scheme for biomanufacturing, and six National BioMissions to make India one of the world’s top three biotechnology powers by 2035. About Bioeconomy Bioeconomy refers to the industrial use of biological resources (plants, animals, microorganisms) and natural biological processes for producing goods and services. Traditional and Expanding Applications Biological resources have long been used in healthcare, pharmaceuticals, and agriculture. Their use is now expanding to fuels, textiles, plastics, construction materials, and chemicals due to their renewability, cost-effectiveness, and sustainability. Sustainable Alternatives Ethanol, produced via fermentation of sugarcane or corn, is replacing hydrocarbon-based fuels. Biotechnology enables biomedicines and synthetic biology, allowing the design of microorganisms with specific traits. Scope for Rapid Growth The economic use of biological resources is still in its early stages but has vast untapped potential. With advancements in biotechnology and sustainability, the bioeconomy is expanding rapidly Key Highlights Proposes a ₹50,000-crore BioEconomy Growth Fund (2026–2035) to support biotechnology innovation and commercialisation. Recommends a Production-Linked Incentive (PLI) Scheme for biomanufacturing. Targets expansion of India’s bioeconomy from $195.3 billion (2025) to $691 billion (2035) and $2.6 trillion (2047). Aims to generate over 30 million high-value jobs. Suggests mission-mode implementation, regulatory reforms, and stronger coordination among ministries. Six National BioMissions GeneIndia : Affordable gene and cell therapies. AgriBio 2.0: Climate-resilient gene-edited crops and biological farm inputs. BioX Foundry : Commercialisation of synthetic biology innovations. One Health Grid : Integrated surveillance of infectious diseases and antimicrobial resistance (AMR). Marine Biotechnology : Seaweed cultivation and marine bioproducts. BioPharmaNext :Global hub for biologics, biosimilars, and AI-enabled drug discovery. CapaCITIES Project Context: The event titled "Scaling Up Urban Climate Resilience: CapaCITIES Achievements and…
